健康资讯 Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-23-007539 Act: 34 Size: 15 MB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002041 Size: 7 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002039 Size: 5 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002038 Size: 4 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-088046 Act: 34 Size: 24 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002200 Size: 8 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) DEF 14A Other definitive proxy statements Accession Number: 0001193125-23-056298 Act: 34 Size: 751 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-080563 Act: 34 Size: 13 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-080560 Act: 34 Size: 17 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-078620 Act: 34 Size: 29 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002199 Size: 8 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-23-065311 Act: 34 Size: 240 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001193125-23-073252 Act: 34 Size: 1 MB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002037 Size: 5 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002198 Size: 8 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 8-K Current report, item 1.01 Accession Number: 0001193125-23-058118 Act: 34 Size: 140 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002197 Size: 6 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002040 Size: 4 KB 网页链接
Akebia Therapeutics(AKBA)：
Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002201 Size: 11 KB 网页链接
